The Food and Drug Administration has approved a molecular test from Roche, which allows health care professionals to screen for the disease in blood, organ, and tissue donors, and thus, reduce the spread of malaria.
The cobas test provides “a highly sensitive and specific solution” to ensure that infected blood units are removed from the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?